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Abstract
Background: The clinical outcome and health-related quality of life (HRQoL) of living kidney donors is mostly not
detrimental, but some donors experience impairment after donation. Gender-specific effects of living kidney donors
was evaluated.
Methods: Clinical outcome was assessed in living kidney donors and HRQoL was obtained by self-reporting
validated test systems as the Multidimensional Fatigue Inventory (MFI-20), the Short Form 36 (SF-36), and the
Patient Health Questionnaire (PHQ-9).
Results: Two hundred and eleven (211) living renal donors were evaluated (female 62.2%). Response rate was 80.8%.
In both genders, a decrease of renal function of 26% was observed after donation. De novo antihypertensives were
introduced in 28.3% of women and 36.5% of men. HRQoL was comparable in female and male donors, except for
mental HRQoL, which was lower in 51- to 60-year-old female donors, compared to age-matched male donors and to
the female general population. Female donors aged 40–59 years demonstrated more fatigue than the age-matched
general population. A low mental HRQoL (MCS; SF-36) was associated with higher values for fatigue (General Fatigue
Score; MFI-20) in both genders. Multiple regression analysis detected the General Fatigue score of the MFI-20
questionnaire and depression identified by the PHQ-9 score as independent variables predicting MCS of the SF-36 in
both genders. Lower age at time of donation contributed to a lower MCS in female donors.
Conclusions: Overall, HRQoL in living kidney donors exceeds that of the general population. Inferior mental health
status and fatigue seem to be a problem, especially in middle-aged female donors, but not in all female donors.
Psychological evaluation pre donation and psychological support post donation are required.
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Background
The number of living renal donations is increasing
worldwide [1]. Altogether, 1921 renal transplantations
were performed in Germany in 2017, of which 557
(29%) kidneys were from a living donor [2]. In all the
cases, a healthy person decided to undergo the risks of
surgery mostly for altruistic reasons [3]. Therefore, living
donation has a special status from the medical and
ethical points of view. However, there are studies that
hint at the presence of fatigue and other psychosocial
problems post donation, particularly for the subgroup of
female donors and maybe also for a special age category
[4, 5]. Gender medicine in living renal donation is of
high importance: there are more women donating an
organ than men, and women are less often given a
kidney by a living donor [6]. Another point is the differ-
ence between male and female living donors concerning
clinical outcome: a study by Mjoen et al. showed that
female donors with a BMI > 25 kg/m2 and an age > 50
years achieved the lowest GFR after donation [7].
Altogether, clinical outcome and HRQoL of living
kidney donors mostly seem to be safe, but some donors
experience impairment after donation. In the present
study, to detect donors at risk, female and male kidney
donors are evaluated concerning physical and psycho-
social outcomes.
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Methods
Study population
The study was designed to assess clinical and psycho-
social outcome in living renal donors with respect to
gender differences. Two hundred and ninety-three (293)
kidney donors were contacted by mail, including an
invitation letter as well as standardised questionnaires.
All these participating respondents donated a kidney
between 08/1983 and 06/2011.
HRQoL assessment and screening for fatigue or
depression was determined by self-reporting validated
test. A representative German adult general population
cohort served as the control group for each question-
naire. A regular clinical follow-up after donation was
performed annually. Psychological counselling was
undertaken for each donor and recipient prior to trans-
plantation and, if necessary, after transplantation.
The study was approved by the institutional Ethics
Committee and was conducted according to the
Declaration of Helsinki 2003. Written informed consent
was obtained from all participating donors.
Questionnaires
Short form 36
The Short Form 36 (SF-36) is a questionnaire to meas-
ure HRQoL containing the eight multi-item subscales:
general health perceptions, physical functioning, physical
role, bodily pain, general mental health, vitality, emo-
tional role, and social functioning. Each subscale has a
range from 0 to 100 with 100 standing for optimal func-
tion. The subscales are then combined into a physical
and mental component summary score (PCS and MCS).
We compared the study population with the German
general population presented by the study of Ellert and
Bellach et al. (6964 persons between the age of 8 and 80
years) [8, 9].
Multidimensional fatigue inventory
The Multidimensional Fatigue Inventory (MFI-20) was
designed to measure chronic tiredness and was originally
conceived for patients with fatigue due to malignoma.
There are 20 items, each consisting of a 5-point Likert
Scale. The 20 items are built on five summary scales:
general fatigue, physical fatigue, mental fatigue, reduced
activity and reduced motivation. A higher score indicates
more fatigue. We compared our study population to the
German general population of Schwarz et al. (2037
persons) [10, 11].
Patient health questionnaire - depression component
questionnaire
The Patient Health Questionnaire (PHQ) was designed
to detect mental disorders. In our study we used the
“depression” component questionnaire of the PHQ
(PHQ-9). The questionnaire consists of 9 Items, each
consisting of a 4-point Likert Scale. The questions in-
clude a period of the last two weeks. A summary score
can be build with the following cut-off scores: 0–4
points indicates no mental disorder, 5–10 points can be
seen as a probable beginning mental disorder. 11–14
points indicate a mild, 15–19 a distinctive and 20–27
a severe form of major depression [12]. We compared
our donors with a normal sample of Kocalevent et al.
(2013) [13].
Statistical analysis
All analyses were performed using IBM SPSS Statistics
for Windows, Version 21.0 (IBM Corp. released 2012;
Armonk NY: IBM Corp.). Values are presented as mean
(SD) or n (%).
Statistical significance was tested with paired and un-
paired t-tests, as well as chi-square distribution. p < 0.05
indicated statistical significance. Multiple linear regres-
sion analyses was performed, using the “Mental Compo-
nent Summary” of the SF-36 as the dependent variable,
and General Fatigue Score, Physical Component
Summary Score, PHQ-9, S-creatinine, age at time of do-
nation and time after donation as independent variables.
Results
Study population
A total of 293 living renal donors were contacted. Out
of 261 expected responses, 211 questionnaires were
returned by donors (80.8%), Fig. 1. Altogether, 131
(62.1%) of the 211 participating renal donors were fe-
male. The return rates, separated by gender, were 76.9%
in male and 69.7% in female donors (p = 0.165). Mean
age at the time of donation was 51.7 ± 9.9 years (female
50.5 ± 9.3 years; male 53.8 ± 10.6 years) and, at time of
the assessment, 61.5 ± 10.2 years (female 60.4 ± 9.6 years;
male 63.2 ± 10.9 years), Table 1. Most of the donors were
spouses (26.1%), mothers (24.6%) or fathers (22.7%).
Male donors were more likely to donate to their children
(60%), whereas female donors were willing to donate to
their children (39.7%) as well as to their husbands
(42.7%).
Demographic data of donors with missing HRQoL
questionnaires (69.5% female) were comparable to the
studied donor cohort with a mean age of 58.4 ± 9.3 years
and stable renal function.
Clinical data
Comparing pre and post donation parameters,
S-creatinine was significantly higher after donation (S-cre-
atinine 0.82 ± 0.16 vs. 1.05 ± 0.23mg/dL, p > 0.001),
Table 2. S-creatinine differed significantly in female and
male donors before and after donation (pre 0.74 ± 0.12
mg/dL vs. 0.94 ± 0.14mg/dl, p < 0.001; post 0.90 ± 0.15 vs.
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Fig. 1 Donor flow chart
Table 1 Patient demographics separated by gender
All donors
N = 211
Female donors
N = 131
Male donors
N = 80
p
Gender, n (%) – 131 (62.1) 80 (37.9) –
Age at the time of donation (years), mean (SD) 51.7 (9.9) 50.5 (9.3) 53.8 (10.6) 0.057
Age at the time of assessment (years), mean (SD) 61.5 (10.2) 60.4 (9.6) 63.2 (10.9) 0.019
Time after donation (years), mean (SD) 9.7 (5.2) 9.9 (5.4) 9.4 (4.8) 0.459
Relationship to recipient, n (%)
Parent (father/mother) 100 (47.4) 52 (39.7) 48 (60) 0.004
Child (son/daughter) 2 (0.9) – 2 (2.5)
Sibling (brother/sister) 28 (13.3) 19 (14.5) 9 (11.3)
Spouse (husband/wife) 71 (33.6) 56 (42.7) 15 (18.8)
Friends, emotionally related 3 (1.4) 1 (0.8) 2 (2.5)
Other related 7 (3.3) 3 (2.3) 4 (5.0)
Children mean (SD) 2.2 (0.90) 2.2 (1.0) 2.1 (0.7) 0.375
Smoking, n (%)
Smoker 34 (16.1) 23 (17.6) 11 (13.8)
Non-smoker 174 (82.5) 107 (81.7) 67 (83.8)
Unknown 3 (1.4) 1 (0.8) 2 (2.5)
Donor medical prevention, n (%)
Yes, routinely 136 (64.5) 89 (67.9) 47 (58.8) 0.176
No 28 (13.3) 11 (8.4) 17 (21.3)
Occasionally 47 (22.3) 31 (23.7) 16 (20.0)
N number, p significance, SD standard deviation
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1.20 ± 0.22mg/dL, p < 0.001). Estimated GFR was
comparable between female and male donors before
and after donation, but decreased significantly after
donation (p < 0.001). Decrease of CKDepi GFR was
24 ml/min in female and 23 ml/min in male donors.
Proteinuria increased after donation in both gender
with significantly higher post donation proteinuria in
male compared to female donors. However, the gen-
eral amount of proteinuria was low.
Mean systolic blood pressure was 131 ± 15 mmHg
and diastolic blood pressure was 82 ± 7 mmHg prior
to donation. Most females demonstrated a blood pres-
sure in the category of high normal or stage 1 hyper-
tension (both 30.6%). Most males also showed high
normal values (31.0%). Especially in female donors,
blood pressure increased significantly after donation.
However, percentages of de novo prescription of anti-
hypertensives after donation was 28.3% in female and
36.5% in male.
Body mass index (BMI), cholesterol and HbA1c did
not differ significantly in female or male donors prior
and post donation, Table 2.
Health-related quality of life (SF-36)
Female and male donors showed comparable results for
PCS (Physical Component Summary Score, 51.8 ± 10.1
vs. 53.9 ± 7.9). Significantly worse results were achieved
by female compared to male donors in MCS (Mental
Component Summary Score, 47.3 ± 13.0 vs. 51.7 ± 11.0,
p = 0.012), Table 3. The best results were achieved in the
scale of “Social Functioning” by male living donors,
whereas female living donors achieved the best results in
the scale of “Physical Functioning”.
In comparison to the German general population,
living renal donors showed significantly higher results in
PCS (52.6 ± 9.3 vs. 48.36 ± 9.42; p < 0.001) and signifi-
cantly lower results in MCS (48.7 ± 19.5 vs. 50.78 ± 8.82;
p = 0.037). Lower MCS results in the donor cohort were
Table 2 Clinical parameters of donors separated by gender after living renal donation
Female Male Significance
Mean (SD) Mean (SD) p
S-creatinine [mg/dL] - pre 0.74 (0.12) 0.94 (0.14) < 0.001
S-creatinine [mg/dL] – post 0.90 (0.15) 1.22 (0.22) < 0.001
Significance p < 0.001 < 0.001
CKD-EPI GFR [mL/min/1.73m2] - pre 93 (14) 91 (14) 0.393
CKD-EPI GFR [mL/min/1.73m2] – post 69 (15) 68 (15) 0.591
Significance p < 0.001 < 0.001
Proteinuria [g/L] - pre 0.04 (0.03) 0.05 (0.08) 0.307
Proteinuria [g/L] – post 0.05 (0.04) 0.08 (0.11) 0.028
Significance p < 0.001 < 0.001
BMI [kg/m2] - pre 25.3 (4.7) 26.2 (3.5) 0.133
BMI [kg/m2] – post 26.4 (4.9) 27.4 (3.5) 0.307
Significance p 0.179 0.058
Blood pressure- systolic [mmHg] - pre 127 (14) 133 (12) 0.001
Blood pressure- systolic [mmHg] – post 131 (15) 132 (15) 0.662
Significance p 0.006 0.568
Blood pressure-diastolic[mmHg] - pre 80 (8) 83 (8) 0.007
Blood pressure-diastolic[mmHg] – post 82 (8) 81 (7) 0.257
Significance p 0.006 0.025
Cholesterol [mg/dL] - pre 214 (39) 213 (38) 0.830
Cholesterol [mg/dL] – post 214 (46) 207 (41) 0.373
Significance p 0.266 0.276
HbA1c [mg/dL] - pre 5.5 (0.5) 5.6 (0.4) 0.239
HbA1c [mg/dL] – post 5.5 (0.4) 5.5 (0.4) 0.912
Significance p 0.186 0.291
BMI body mass index, CKD-EPI chronic kidney disease epidemiological, GFR glomerular filtration rate, HbA1c haemoglobin A1c, N number, p significance, S serum,
SD standard deviation
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induced due to significantly lower MCS in female donors
compared to females in the German general study popu-
lation, whereas male revealed no difference.
Further analysis revealed that the female donor
group aged 51 to 60 years contributed to this
phenomenon with lower results in MCS (41.4 ± 14.6
vs. 50.1 ± 9.6, p < 0.001) and in the subscale of “Men-
tal Health” (65.4 ± 41.6 vs. 84.2 ± 30.7, p = 0.002) in
comparison to the age- and gender-matched German
general population. All other age groups in all sub- and
summary scales showed comparable or even better results.
Also in comparison to male donors, only female donors
aged 51–60 years revealed significantly worse results in
MCS (41.6 ± 14.7 vs. 51.5 ± 8.9, p = 0.008). Male donors
showed comparable or even significantly better results in
PCS and MCS, compared to the age- and gender-matched
German general population.
Fatigue (MFI-20)
Comparing female and male donors, a significant dif-
ference was detected in the scale of “General Fatigue”
with women showing higher, i.e. worse, results than
men (9.9 ± 4.7 vs. 8.4 ± 4.0, p = 0.013). Especially
female donors aged 40–59 years showed significantly
higher results in the scales of “General Fatigue” (11.2 ± 4.7
vs. 8.7, p < 0.001) and “Physical Fatigue” (9.7 ± 4.5 vs. 8.2,
p = 0.014) than the age- and gender-matched German gen-
eral population, Table 4. The age group of > 60-year-old
female as well as male donors showed significantly lower
results in almost all the fatigue scales.
Depression (PHQ-9)
Male and female donors presented a mean value of
3.86 ± 4.15, which is far under the cut-off score of 10
points for depressive disorders (male: 3.24 ± 3.48,
female: 4.26 ± 4.50; p = 0.087), Table 5. Only 6.3% of
the male and 10.5% of the female donors presented
PHQ-9 values above 10 points. In comparison to the
German normal population (N = 5018) the donor co-
hort showed a significantly higher summary score
(2.91 ± 3.52 vs. 3.86 ± 4.15, p = 0.001). Separated by
gender and age, the male as well as the female
donors showed comparable or even better (> 75 year
old male and females: 3.1 ± 3.2 vs. 4.4 ± 3.9, p = 0.041)
results than the age- and gender- matched German
normal sample.
Multiple regression analyses
Multiple regression analysis identified fatigue symptoms
detected by the General Fatigue score of the MFI-20
questionnaire and depression perceived by the PHQ-9
score as independent variables predicting MCS of the
SF-36 in both genders (Table 6). Lower age at time of
donation supported a lower MCS in female donors.
Characteristics of middle-aged female donors with
impaired quality of life
To further analyse impaired quality of life in female
donors aged 51–60 years we evaluated female donors of
this age-group with results lower than two standard de-
viations from the mean value of the age and gender
matched German general population in the MCS of the
SF-36 (n = 15) and compared them with female donors
above this value, Additional file 1: Table S1.
No significant difference could be detected in renal
function of the donor (S-creatinine, p = 0.227), renal
function of recipient (S-creatinine, p = 0.961) or loss of
kidney transplant of the recipient (p = 1.000). Female do-
nors who showed very low results in MCS also showed
significantly higher values for fatigue (p < 0.001) in
Table 3 Short Form 36 (SF-36): Mean (SD) of the subscales and physical and mental component summary score in living renal
donors compared to the German general population of 1998 separated by gender [11]
Female Male
Mean (SD) female donors Mean female German
reference (1998)
p Mean (SD) male donors Mean male German
reference (1998)
p
PF 82.70 (21.84) 82.77 0.972 88.73 (14.15) 88.18 0.729
RP 78.46 (34.83) 79.22 0.804 88.46 (26.02) 85.53 0.323
BP 74.35 (28,34) 63.89 < 0.001 82.43 (23.74) 71.04 < 0.001
GH 69.77 (18.37) 66.03 0.021 70.22 (18.07) 66.83 0.102
VT 59.78 (19.73) 57.57 0.201 67.03 (17.82) 62.58 0.030
SF 81.06 (25.49) 84.24 0.157 90.94 (16.15) 88.63 0.205
RF 80.77 (35.43) 86.74 0.057 87.61 (28.98) 91.58 0.230
MH 70.14 (19.80) 69.83 0.857 76.56 (17.72) 75.22 0.505
PCS 51.79 (10.05) 47.49 < 0.001 53.89 (7.94) 49.26 < 0.001
MCS 47.26 (12.96) 49.85 0.026 51.71 (11.0) 51.92 0.868
PF Physical Functioning, RP Role Percept-ion, BP Bodily Pain, GH General Health Percept-ion, VT Vitality, SF Social Func-tioning, RF Role Functioning, MH Mental
Health, PCS Physical Component Summary Score; MCS, Mental Component Summary Score; p, significance; SD, standard deviation
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comparison to female donors with normal value in
MCS. These women presented very low results in the
subscale “emotional role functioning” of the Short-Form
36 in comparison to the age- and gender-matched normal
population (15.56 ± 21.33 vs. 84.16 ± 30.70, p = 0.002).
Most of theses 15 women donated the kidney to their
husband (N = 7), followed by donating to their child (N =
6), the others donated to their brother/sister (N = 2); 53.3%
(n = 8) were working in a part time job, 3 in a full time job
(others: retired n = 1, unemployed n = 1, housewife n = 2).
These women had 2.08 children (range 1–3). Mean age at
time of donation was 45.1 ± 7.7 years. Mean GFR was 73 ±
17ml/min/1.73m2 and S-creatinine was 0.88 ± 0.13mg/dL.
Mean arterial pressure was 99 ± 9mmHg at the time of
donation.
Discussion
Altogether, 211 living renal donors were evaluated con-
cerning clinical and psychosocial outcome. There was no
difference in terms of gender concerning the renal function
at about ten years post donation, whereas S-creatinine was
significantly higher in the males. The psychosocial evalu-
ation of the donor cohort revealed better results in HRQoL
in male and female donors, expect for the patient group of
Table 4 Multidimensional Fatigue Inventory (MFI-20): Mean (SD) of the MFI-20 scales in living renal donors compared to the
German general population separated by gender and age [15]
Female Male
Age ≤39a Age 40–59 Age ≥ 60 Age ≤39a Age 40–59 Age≥ 60
General Fatigue
N 3 60 68 1 29 48
Mean 7.67 11.16 8.96 17.0 9.21 7.65
SD 2.52 4.74 4.43 – 4.09 3.70
German reference (Mean) 7.7 8.7 10.8 6.6 8.0 10.1
p – < 0.001 0.001 – 0.123 < 0.001
Physical Fatigue
N 3 59 68 1 29 50
Mean 8.0 9.7 7.91 11.0 8.08 7.5
SD 4.58 4.52 3.36 – 3.74 3.26
German reference (Mean) 6.8 8.2 11.1 6.1 7.6 10.3
p – 0.014 < 0.001 – 0.495 < 0.001
Reduced Activity
N 3 60 68 1 29 50
Mean 6.33 9.09 7.63 15.0 7.91 7.66
SD 2.08 4.37 3.48 – 3.9 3.54
German reference (Mean) 7.1 8.2 10.5 6.4 7.6 10.3
p – 0.121 < 0.001 – 0.674 < 0.001
Reduced Motivation
N 3 60 68 1 29 50
Mean 6.67 7.68 7.16 17.0 8.07 7.26
SD 3.79 3.54 3.28 – 4.41 3.15
German reference (Mean) 6.7 8.0 9.9 6.2 7.6 9.1
Significance – 0.484 < 0.001 – 0.571 < 0.001
Mental Fatigue
N 3 60 68 1 29 50
Mean 7.67 7.82 7.57 19.0 8.34 7.9
SD 4.73 4.17 3.54 – 3.65 3.11
German reference (Mean) 7.1 7.8 9.2 6.4 7.1 8.7
p – 0.967 < 0.001 – 0.077 0.075
aNo analysis of this group because of too small number of cases
p significance, SD standard deviation
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51- to 60-year-old female donors. Evaluation of fatigue by
the MFI-20 questionnaire demonstrated comparable
results for both genders, except for the scale of “General
Fatigue” in female donors aged 40 to 59 years who obtained
worse results than male donors.
The response rate of 80.8% was comparable to
other psychosocial outcome evaluations in renal
donors [14, 15]. The mean age of the living female
donors in this study was 60.4 ± 9.6 years and the
mean age of male donors was 63.2 ± 10.9 years.
Overall, 55.9% of the donors were aged > 60 years.
Dols et al. could not show a significant difference in the
decline of GFR, in a comparison between donors < 60
years and donors > 60 years, with older donors already
demonstrating a lower GFR prior to donation [16].
However, in this study no disadvantage due to increased
age could be shown.
Concerning blood pressure, there were no significant
differences between men and women, or between time
pre and post donation. However, 28.3% of the females
and 36.5% of the males obtained de novo antihyperten-
sive drugs after donation. Fehrman-Ekholm et al. dem-
onstrated comparable results: 23% of the donors needed
de novo antihypertensive drugs after donation, and 22%
demonstrated a newly diagnosed arterial hypertension
[17]. Nevertheless, the prevalence of hypertension in the
German general population is similar, at 29.9% in
females and 33.3% in males [18].
Table 5 PHQ-9 “Depression”: Comparison of living renal donors (a. female, b. male) with the German general population of
Kocalevent et al. (2013) in age classes [13]
Age categories Mean (SD) N Mean (SD) N Signa
a
Female donors Women of the German normal population
25–34 years 1.0 (−) 1 2.5 (3.0) 351 –
35–44 years 4.3 (3.6) 6 2.8 (3.6) 542 –
45–54 years 3.7 (3.8) 26 2.7 (3.3) 457 0.174
55–64 years 4.4 (4.9) 43 3.3 (3.4) 446 0.125
65–74 years 4.8 (5.1) 39 3.6 (3.6) 395 0.163
≥75 years 3.0 (2.2) 9 4.5 (3.5) 236 0.076
b
Male donors Men of the German normal population
25–34 years 1.0 (−) 1 2.0 (3.2) 279 –
35–44 years 4.3 (6.0) 4 2.3 (3.3) 396 –
45–54 years 4.1 (3.7) 18 2.9 (3.7) 414 0.174
55–64 years 2.7 (3.3) 22 3.1 (3.6) 398 0.584
65–74 years 2.9 (2.8) 18 3.0 (3.6) 397 0.855
≥75 years 3.1 (3.6) 18 4.1 (4.4) 156 0.266
aunpaired T-Test
Table 6 Multiple Regression Analysis. Presenting regression coefficient β, standard error and significance p of the presented
independent variables on the dependent variable “Mental Component Summary Score” of the Short-Form 36, separated by gender
Female Donors Male Donors
Regression
Coefficient β
Standard error p Regression
Coefficient β
Standard error p
(constant) 71.812 11.209 0.000 82.210 15.308 0.000
Age at time of donation 0.178 0.077 0.023 0.055 0.078 0.487
Mean arterial pressure post donation −0.127 0.076 0.100 −0.062 0.107 0.568
Renal function (S-creatinine mg/dL) post donation 1.981 2.224 0.375 −1.050 3.759 0.781
Recipient outcome −0.451 0.417 0.282 0.125 0.594 0.834
Physical Component Summary Score −0.066 0.082 0.424 −0.192 0.119 0.112
General Fatigue −1.347 0.220 0.000 −1.249 0.299 0.000
PHQ-9 −1.445 0.255 0.000 −1.461 0.306 0.105
MCS Mental Component Summary Score, PCS Physical Component Summary Score, S serum, PHQ-9 Depression Patient Health Questionnaire
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Renal function was estimated by the CKD-EPI
formula. This formula provides the most precise results
in the Normal to Stage CKD II categories [19]. No pa-
tient in this study showed an eGFR below 30 mL/min/
1.73m2. Corresponding to previous evaluations, a mean
decrease of 26% was noted after donation [17, 20]. eGFR
and change in renal function were equivalent in both
genders. In a study by Ibrahim et al., a mean eGFR
decrease of 24% was noted [21]. A better compensation
of the GFR was possible at a younger age, longer time
since donation and a higher estimated GFR at the time
of donation. Mjoen et al. revealed women aged > 50
years with a BMI > 25 kg/m2 as being at high risk for
decreased renal function [7]. In a most recent study,
GFR decreased about 33.6% and was longitudinally
lower among men than women, without any association
to HRQoL [22].
Physical and mental HRQoL assessed by the SF-36
questionnaire was significantly better in male living
donors in total and in different age groups, than in
males of the German general population [9]. Female do-
nors in this study showed significantly better physical
HRQoL, in comparison to the female general population,
but reduced mental health in comparison to the general
population. Women aged 51–60 years in particular
achieved lower results in mental health. On the contrary,
Ibrahim et al. showed better results for both genders in
comparison to the US general population [21]. In a re-
cently published study, donors felt positive about dona-
tion and there was no evidence of a significant change in
psychosocial outcomes [23]. Timmerman et al. evaluated
the importance of psychological factors on mental health
after living renal donation [24]. Lower age, lack of social
support, expectation of interpersonal benefit, an avoi-
dant coping style were identified as indicators of a lower
mental health status. Kroencke et al. demonstrated that
the donor-recipient relationship might influence HRQoL
outcome in living renal donation. Adult-to-paediatric
donors experienced more preoperative psychological
stress, which improved after donation, whereas
adult-to-adult donors showed unchanged anxiety and
depression, and a slight decrease in mental health [25].
Female donors of our study, who had results below two
standard deviations in MCS of the Short-Form 36
donated mostly to a child as well as to their husband.
Important results were found in the present study: low
results in MCS of the SF-36 came along with higher
values for Fatigue (MFI-20). These findings are in line
with de Groot et al., who identified higher fatigue in all
dimensions of the MFI-20 in donors (female and male)
with reduced PCS and MCS subscales [15].
Fatigue is not easily measured objectively and mostly
set as a diagnosis by exclusion. A lot of differential diag-
noses, such as somatoform disorder or depression have
to be considered. Demyttenaere et al. showed fatigue as
a common symptom of a major depression, whereas
Artom et al. showed fatigue in advanced kidney diseases
as a diagnosis in itself [26, 27]. In a Norwegian analysis
female sex in general was significantly associated with
general fatigue [28]. In our study women aged 40 to 59
years showed significantly worse results in the “General
Fatigue” scale and the “Physical Fatigue” scale, whereas
women aged > 60 years showed significantly better
results than the German general female population. In
contrast to other evaluations, a linear correlation
between age and fatigue therefore could not be noted in
the present study [11, 29].
Female donors especially of the age group of 51–60
years seem to be at a higher risk for low mental health
after living renal donation, although the reason for that
fact remains unclear. Our results show that the outcome
of recipients, measured by S-creatinine, did not correlate
with a bad mental health of the donors. Lopez et al.
showed a significant correlation between low resilience,
depressive symptoms and being in peri-menopause [30].
Perhaps women at the age of 51–60 years have to deal
with a lot of stressors e.g. changing of the body in meno-
pause, children who become adults and maybe own
parents who have to be cared about. Further analyses of
this special age group should be performed in following
studies.
The benefit of the present study is that it provides a
comprehensive evaluation including physical, mental
and social outcome of all living renal donors at the
Transplant Centre of Heidelberg. Limitations of this
study include the cross-sectional evaluation of HRQoL,
whereas the clinical follow-up was assessed prospectively
in yearly follow-up visits. Nearly 19.8% of the kidney
donors refused to complete the self-reported question-
naires. However, demographics of these donors were
similar to the assessed donors. There is no consent among
experts as to the best control group. Comparing living do-
nors to national data may underestimate the psychosocial
impairment attributable to kidney donation.
Conclusions
In conclusion, no significant difference between female
and male donors concerning physical outcome could be
detected. HRQoL is mostly comparable, or even better,
in kidney donors compared to the general population.
Limited HRQoL and fatigue symptoms seem to be a
problem especially in middle-aged female donors, but
not in all female donors. This special patient cohort
could be identified by low mental health or high fatigue.
Therefore, we suggest psychological counselling as part
of the evaluation of potential living renal donors as well
as part of the after-care programme.
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